Editing Instem plc: $12m five-year agreement with Leading Contract Research Organisation
Revision as of 13:22, 2 September 2022 by Manos (talk | contribs) (Created page with "02 September 2022 $12m five-year agreement with Leading Contract Research Organisation Further growing SaaS revenues with long-term client Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces a five-year agreement, worth over $12 million, with a leading global contract research organisation ("CRO" or "Client") to support over 2,000 users worldwide in their clinical trial analysis. The Client, which has been a clinica...")
Warning: You are editing an out-of-date revision of this page. If you publish it, any changes made since this revision will be lost.
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.